Cargando…
Antiviral Activity of Vacuolar ATPase Blocker Diphyllin against SARS-CoV-2
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) is a causative agent of the pandemic coronavirus disease 2019 (COVID-19), which has resulted in over two million deaths worldwide to date. Diphyllin and diphyllinosides are known as natural blockers of cellular vacuolar ATPases, and so can...
Autores principales: | Stefanik, Michal, Strakova, Petra, Haviernik, Jan, Miller, Andrew D., Ruzek, Daniel, Eyer, Ludek |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7996309/ https://www.ncbi.nlm.nih.gov/pubmed/33668694 http://dx.doi.org/10.3390/microorganisms9030471 |
Ejemplares similares
-
Diphyllin Shows a Broad-Spectrum Antiviral Activity against Multiple Medically Important Enveloped RNA and DNA Viruses
por: Štefánik, Michal, et al.
Publicado: (2022) -
Arbidol (Umifenovir): A Broad-Spectrum Antiviral Drug That Inhibits Medically Important Arthropod-Borne Flaviviruses
por: Haviernik, Jan, et al.
Publicado: (2018) -
Inhibitory and combinatorial effect of diphyllin, a v-ATPase blocker, on influenza viruses
por: Chen, Hui-Wen, et al.
Publicado: (2013) -
Nanoparticulate vacuolar ATPase blocker exhibits potent host-targeted antiviral activity against feline coronavirus
por: Hu, Che-Ming Jack, et al.
Publicado: (2017) -
Antiviral activity of singlet oxygen-photogenerating perylene compounds against SARS-CoV-2: Interaction with the viral envelope and photodynamic virion inactivation
por: Straková, Petra, et al.
Publicado: (2023)